G2’s Lab Institute Returns in Virtual Format
This digital event will help labs meet the various legal, compliance, business, and technology challenges of the industry, today and tomorrow.
New Laws Seek to Protect Healthcare Workers from Violence
With threats and attacks increasing, Congress has tabled a bill that would impose extra penalties on those seeking to harm healthcare staff.
How to Make Genetic Testing Relevant for All Groups
Researchers propose solutions to underrepresentation of certain groups in genetic databases, based on two recent initiatives.
New Resource Aims to Improve Diagnosis of Patients with Hearing Loss
Guidance from the American College of Medical Genetics and Genomics shares the importance of a genetic evaluation for hearing loss.
2022 Laboratory and Pathology Coding, Billing, and Reimbursement Update
This free webinar addresses annual billing changes and critical developments currently facing laboratory medicine.
FDA Watch: What Labs Need to Know About New Medical Device Cybersecurity Rules
As of October 1, medical device makers must include information about their products’ vulnerabilities when seeking premarket authorization.
Information Blocking: Everything You Need to Know
This session will offer an understanding of the Cures Act, as well as responsibilities and opportunities available to laboratories as a result of the law.
The Basics of Business Associate Agreements (BAAs) for Labs
When it comes to protected health information, it’s important that labs manage contracts with external sources to ensure HIPAA compliance.
Privacy in the Post Roe v. Wade World: How Could Proposed HIPAA Restrictions on Reproductive PHI Affect Labs?
Key points labs should know about the recently proposed OCR rule on privacy protections for PHI associated with reproductive health care.
Enforcement Trends: Six Ways Your Lab Can Avoid HIPAA Right of Access Issues
An analysis of recent OCR enforcement actions and settlements identifies the common pitfalls labs should watch out for.
Expert Q&A: Developments in Noninvasive Prenatal Testing
Diana W. Bianchi, MD, discusses how NIPT has evolved, key challenges, as well as her team’s research on using these tests to detect cancer.
Which Test? Choosing the Best Approach to Diagnosing Rare Disease
Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.
Streamlining Lab Operations with Software Automation
Using LIMS and no-code solutions can unlock opportunities for efficiency.
Pursuing the PFAS Problem
Tackling the challenges of “forever chemicals” in the diagnostics industry.
Dx Deal Roundup: Key Acquisitions for Danaher & Exact, and a Big AI Partnership
Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.